Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 4UNKNOWN 1OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 7Breast Neoplasms 7Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 2Neoplasm Metastasis 2Carcinoma, Non-Small-Cell Lung 2Brain Neoplasms 2Thymoma 1Thoracic Neoplasms 1Stomach Neoplasms 1Skin Diseases 1Recurrence 1Rectal Neoplasms 1Pain 1Neutropenia 1Neoplasms by Site 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer 1Gastric Adenocarcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ductal, Breast 1Carcinoma 1Cancer Pain 1Breast Diseases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × UNKNOWN × Gastric Adenocarcinoma × Clear all
NCT02512380 2015-08-10

Neoadjuvant SLOT Versus SOX in Patients With Locally Advanced, Resectable Gastric/Esophagogastric Junction (EGJ) Cancer

ChineseAMS

Phase 3 Unknown
380 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡